95-8067. Food Labeling; Placement of the Nutrition Label on Food Packages  

  • [Federal Register Volume 60, Number 65 (Wednesday, April 5, 1995)]
    [Rules and Regulations]
    [Pages 17202-17208]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-8067]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 101
    
    [Docket No. 93N-0283]
    RIN 0905-AD89
    
    
    Food Labeling; Placement of the Nutrition Label on Food Packages
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending its food 
    labeling regulations to provide increased flexibility in the placement 
    of the nutrition label on packaged foods. In situations in which the 
    principal display and information panels cannot accommodate all the 
    required labeling information, and the package has a total surface area 
    available to bear labeling of greater than 40 square inches (sq in), 
    the amendment allows the nutrition label to be placed on any panel that 
    can be readily seen by the consumer. This action is being taken in 
    response to comments received on the final rule of January 6, 1993, 
    entitled ``Food Labeling Regulations Implementing the Nutrition 
    Labeling and Education Act of 1990; Opportunity for Comments,'' 
    (hereinafter ``the implementation final rule''), and on the proposed 
    rule of August 18, 1993, entitled ``Food Labeling; Placement of the 
    Nutrition Label on Food Packages.''
    
    EFFECTIVE DATE: May 5, 1995.
    
    FOR FURTHER INFORMATION CONTACT: Arletta M. Beloian, Center for Food 
    Safety and Applied Nutrition (HFS-165), Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-205-5430.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
    A. The Principal Display Panel and Information Panel
    
        Under FDA's regulations (Sec. 101.1 (21 CFR 101.1)), the part of a 
    label that is most likely to be displayed, presented, shown, or 
    examined by a consumer under customary conditions of display for retail 
    sale is called ``the principal display panel.'' This panel must include 
    the statement of identity for the product and its net weight. In 
    addition, to provide consistency and uniformity in the presentation of 
    label information to consumers, FDA has provided for a second display 
    panel for information that must be included on the label but that is 
    not required to appear on the principal display panel. This alternate 
    panel is called ``the information panel'' (Sec. 101.2 (21 CFR 101.2)).
        The information panel is defined in Sec. 101.2(a) as that part of 
    the label that is immediately contiguous and to the right of the 
    principal display panel. Section 101.2(a)(1) specifies that if the 
    first panel to the right of the principal display panel is too small to 
    accommodate the necessary information, or is otherwise unusable label 
    space, the panel immediately contiguous and to the right of that part 
    of the label may be used as the information panel. Accordingly, FDA's 
    regulations direct manufacturers to move the information required to 
    appear on the information panel as a unit when the first available 
    information panel will not accommodate all the required information. 
    Pursuant to Sec. 101.2(e), all information appearing on the information 
    panel must be presented in one place without other intervening 
    material.
        Section 101.2(b) states that the ingredient listing; name and place 
    of business of the manufacturer, packer, or distributor; and nutrition 
    information must appear either on the principal display panel or on the 
    information panel, unless otherwise specified by regulation. Section 
    101.2(d)(1) requires that all information required to appear on the 
    principal display panel or the information panel appear on the same 
    panel unless there is insufficient space, in which case it may be 
    divided between the principal display panel and information panel in 
    accordance with Secs. 101.1 and 101.2. In determining the sufficiency 
    of the available space, under Sec. 101.2(d)(1), any vignettes, designs, 
    and other nonmandatory label information are not to be considered.
    
    B. Mandatory Nutrition Labeling
    
        In the Federal Register of January 6, 1993, FDA issued a final rule 
    entitled ``Food Labeling: Mandatory Status of Nutrition Labeling and 
    Nutrient Content Revision, Format for Nutrition Label'' (58 FR 2079) 
    (hereinafter referred to as ``the mandatory nutrition labeling final 
    rule''), which included provisions to require nutrition labeling on 
    most foods that are regulated by FDA and to specify a new format for 
    declaring nutrition labeling. FDA took this action, in part, to 
    implement the Nutrition Labeling and [[Page 17203]] Education Act of 
    1990 (Pub. L. 101-535), which amended the Federal Food, Drug, and 
    Cosmetic Act. Section 101.9(i) (21 CFR 101.9(i)), which FDA added to 
    its regulations as part of the mandatory nutrition labeling final rule, 
    states that, except as provided in Sec. 101.9(j)(13), the location of 
    the nutrition label must be in accordance with Sec. 101.2.
        In recognizing the demands for label space made by nutrition 
    labeling, the agency included a provision in the mandatory nutrition 
    labeling final rule that allows nutrition information to be presented 
    on any label panel on packages that have a total surface area available 
    to bear labeling of 40 sq in or less (see Sec. 101.9(j)(13)(ii)(D)). 
    The flexibility provided by this provision reflects the agency's 
    recognition that it is more important that the nutrition information be 
    presented on the immediate package than that it be presented in any 
    particular place (58 FR 2079 at 2156). FDA stated that given the 
    consistent appearance of the nutrition information that will be 
    produced by the format elements that it adopted, and the educational 
    efforts of government, industry, and consumer organizations, consumers 
    will know to look for, and be able to recognize, nutrition information, 
    even if it is not presented to the right of the principal display 
    panel. Section 101.9(j)(13)(ii)(D) does not provide an exception, 
    however, for the placement of nutrition information on packages of more 
    than 40 sq in when the principal display and information panels of 
    those packages cannot accommodate all of the required information.
        On January 6, 1993, the agency published, along with the mandatory 
    nutrition labeling final rule and various other final rules, the 
    implementation final rule (58 FR 2066). This document gave interested 
    persons 30 days to comment on any technical issues that had not been 
    raised in earlier comments. In response to this document, FDA received 
    a number of comments that requested greater flexibility in the 
    placement of the nutrition label because of the increased amount of 
    space needed to meet the type size and spacing requirements of the new 
    nutrition label. These comments included product labels that 
    illustrated the difficulties presented in trying to place the required 
    label information on the information panel.
        In the Federal Register of August 18, 1993 (58 FR 44091), FDA 
    published a proposed rule, entitled ``Food Labeling; Placement of the 
    Nutrition Label on Food Packages,'' to amend its regulations on the 
    placement of nutrition information on packages having a total surface 
    area for labeling of greater than 40 sq in. For such situations, the 
    agency proposed to add Sec. 101.9(j)(17). Under this provision, when 
    the package cannot accommodate all information required by regulation 
    on its principal display panel and information panel, the nutrition 
    label may be moved to any alternate panel that can be readily seen by 
    the consumer. Furthermore, under proposed Sec. 101.9(j)(17), the space 
    needed for vignettes, designs, and other nonmandatory label information 
    may be considered when determining the sufficiency of available space 
    on the principal display panel. FDA also proposed to revise: (1) 
    Sec. 101.9(i) to make reference to the exemption from Sec. 101.2 for 
    products covered by proposed Sec. 101.9(j)(17), and (2) 
    Sec. 101.2(d)(1) to exclude from its coverage products that are exempt 
    under Sec. 101.9(j)(17). FDA also proposed to make a number of 
    ancillary modifications to all of the regulations that pertain to 
    relative nutrient content claims, specifically to those sections that 
    require that the statement that compares the amount of the subject 
    nutrient in the product per labeled serving with that in the reference 
    food appear either adjacent to the most prominent claim or on the 
    information panel. Under the proposed modification, the comparative 
    quantitative information may be placed either adjacent to the most 
    prominent claim or to the nutrition label, without regard to the panel 
    on which the nutrition label appears. The agency proposed to make this 
    modification to each regulation in part 101 (21 CFR part 101) that 
    pertains to relative nutrient content claims (e.g., ``more,'' 
    ``light'').
        In addition, in response to other comments that FDA received on the 
    implementation final rule, the agency proposed to amend 
    Sec. 101.61(c)(2)(iii) to require that the statement ``not a sodium 
    free food'' on foods that are not sodium free and yet whose label bears 
    a claim of ``unsalted'' be placed adjacent to the nutrition label 
    rather than on the information panel.
        Interested persons were given until October 18, 1993, to comment on 
    the proposal.
    
    II. Comments and the Agency's Response
    
        FDA received 19 letters, each containing 1 or more comments, in 
    response to the proposal from trade associations, food manufacturers, a 
    state government, and a foreign government. The comments unanimously 
    supported the proposal. However, a few comments contained suggestions 
    for clarifying the regulations and for modifying additional related 
    sections that were not covered in the proposal. FDA is responding to 
    these comments in this document. In addition, the agency received a few 
    comments that addressed issues such as type size and leading (i.e., 
    format) requirements and specific problems pertaining to the placement 
    of the ingredient list on multi-packs of ready-to-eat cereals. These 
    issues are outside the scope of the proposal, and therefore FDA will 
    not address them in this document.
    
    A. Flexibility in Placement
    
        1. All the relevant comments supported FDA's proposal in 
    Sec. 101.9(j)(17) to allow consideration of the space needed for 
    vignettes, designs, and other nonmandatory label information on the 
    principal display panel in deciding whether the space on that panel and 
    the information panel is adequate for presentation of the nutrition 
    label. One comment, however, objected to the agency's failure to 
    provide for consideration of nonmandatory information on the 
    information panel as part of the determination as to whether there is 
    sufficient space available for the nutrition label. The comment stated 
    that the agency's position that the nutrition facts box will be so 
    recognizable that consumers will not have difficulty locating it 
    regardless of where it appears on the label seems to support giving 
    consideration to space needs for vignettes, designs, and other 
    nonmandatory information on the information panel as well as on the 
    principal display panel. The comment asked that the agency clarify its 
    intent and permit nonmandatory label information on the information 
    panel to be taken into account when deciding whether there is 
    sufficient space on that panel for the nutrition facts box.
        The agency's intent in this rulemaking was not to remove all 
    constraints on the placement of the nutrition label but rather to 
    provide added flexibility when needed by industry to facilitate placing 
    the new nutrition label on food packages. In attempting to accomplish 
    this purpose, the proposal did not address the issue of nonmandatory 
    information on the information panel. The agency did not see a need to 
    alter the current requirement in Sec. 101.2(d)(1) that all required 
    information (including the nutrition label; the ingredient list; the 
    name and place of business of the manufacturer, packer, or distributor; 
    and the percent juice declaration) be placed on the information panel, 
    if not on the principal display panel, when there is sufficient space 
    to do so.
        In support of the proposal, FDA noted that the appearance of many 
    packages [[Page 17204]] could be significantly affected if regulations 
    did not allow vignettes, designs, and other nonmandatory information on 
    the principal display panel to be considered in calculating the amount 
    of available label space. The agency also noted that current industry 
    practice almost never places the nutrition label on the principal 
    display panel unless there is no alternative panel on the package. 
    These two factors, which were the impetus for the subject proposal, do 
    not apply to vignettes, designs, and other nonmandatory information on 
    the information panel. Thus, the interests of consumers will be served 
    best by continuing to have this information appear together wherever 
    possible. Moreover, having the nutrition label, the ingredient list, 
    and the name and place of business of the manufacturer, packer, or 
    distributor appear on the same panel simplifies the consumers' search 
    for this information. The comment did not advance any arguments that 
    suggested a countervailing benefit to the public from allowing 
    nonmandatory label information to replace nutrition labeling on the 
    information panel. Accordingly, the agency is not making the requested 
    change.
        2. One comment stated that the second sentence of proposed 
    Sec. 101.9(j)(17) needed to be clarified because there was confusion in 
    trade publications about the significance of nonmandatory information 
    on the information panel.
        FDA agrees that it is necessary to clarify the differences in the 
    agency's treatment of nonmandatory information on the principal display 
    panel as opposed to on the information panel. Accordingly, the agency 
    is revising Sec. 101.9(j)(17) to add a sentence at the end of the 
    subparagraph that reads: ``Nonmandatory label information on the 
    information panel shall not be considered in determining the 
    sufficiency of available space for the placement of the nutrition 
    label.''
    
    B. Statements of Ingredients, and Name and Place of Business
    
        FDA did not propose to modify the requirement that manufacturers 
    list ingredient information and the name and place of business of the 
    manufacturer, packer, or distributor on the principal display panel or 
    the information panel. Under Sec. 101.9(j)(13) and proposed 
    Sec. 101.9(j)(17), only the nutrition label could be placed on another 
    panel.
        3. Three comments urged that the agency allow the ingredient 
    statement (Sec. 101.4) and the name and place of business of the 
    manufacturer, packer, or distributor (Sec. 101.5) to be presented 
    adjacent to the nutrition label on any other label panel that can be 
    readily seen by consumers when the information panel is too small to 
    accommodate all the required information. They argued that, although 
    consumers may now look for the ingredient list and the name and place 
    of business statement on the principal display panel or information 
    panel, it was likely that these statements would be seen if listed on 
    the same panel as the nutrition information, which must be readily 
    observable. Furthermore, the comments argued, consumers are accustomed 
    to seeing all of this information on one panel, and manufacturers often 
    incorporate the ingredient list, the name and place of business 
    statement, and the nutrition label into one design.
        Among these comments, one recommended revised wording in 
    Sec. 101.4(a)(1) to implement the change, i.e., to state that 
    ingredients are to be listed on either the principal display panel, the 
    information panel, or the label panel on which the mandatory nutrition 
    information appears. The comment stated that because Sec. 101.5(a) 
    requires that the label of a food in package form specify conspicuously 
    the name and address of the manufacturer, packer, or distributor, that 
    regulation need not be amended because it allows manufacturers the 
    option of placing such information in a place where the consumer will 
    see it.
        The agency has considered these comments and is not making the 
    requested change because a change of the magnitude of that suggested 
    was not foreshadowed by the proposal. The ingredient statement and the 
    name and place of business statements have appeared on either the 
    principal display or the information panels for nearly 20 years. 
    Allowing the ingredient list and the name and place of business of the 
    manufacturer, packer, or distributor to move off the information panel 
    whenever there is insufficient space for them to appear with the 
    nutrition label would represent a significant redefinition of what 
    constitutes the information panel. While the portion of the food supply 
    that would be affected is unknown, it could be substantial. Companies 
    interested in pursuing this suggestion should submit a citizen petition 
    under Sec. 10.30 (21 CFR 10.30) that would address the possible 
    ramifications of such a change on food packages and on consumers' use 
    of the required label information.
        It should be noted, however, that under Sec. 101.2(a)(1), when 
    there is insufficient space on the panel immediately contiguous and to 
    the right of the principal display panel for all required components, 
    the ingredient list; the name and place of business of the 
    manufacturer, packer, or distributor; and the nutrition label may be 
    moved as a unit to the next panel immediately contiguous and to the 
    right of that panel.
    
    C. Clarification
    
        4. One comment requested that FDA allow for the placement of 
    nutrition information on either side of a center-seamed back panel, 
    such as on flexible film bags used for snack foods that do not have 
    information printed on the sides, top, or bottom of the package. The 
    comment argued that the bag is easily rotated from front to back, and 
    that the full center-seamed back panel is in plain view.
        Section 101.2(a) states that the ``information panel'' is that part 
    of the label immediately contiguous and to the right of the principal 
    display panel when observed facing the principal display panel. If the 
    part of the label immediately contiguous and to the right of the 
    principal display panel is too small to accommodate the necessary 
    information, the next panel immediately contiguous and to the right of 
    the fold may be used (see Sec. 101.2(a)(1)). In the case of flexible 
    film bags of snack foods with folded or pleated side panels that do not 
    provide any additional usable label space, the back panel of the bag is 
    the information panel. FDA interprets the back panel to be the full 
    back panel of the flexible bag, regardless of the presence or absence 
    of a seam. Therefore, the nutrition label may be located on any part of 
    the back panel. Wherever it is placed, however, Sec. 101.2(e) requires 
    that there be no intervening material between it and the other pieces 
    of required information.
    
    III. Other Provisions
    
        5. All comments addressing the aspect of the proposal on relative 
    nutrient content claims supported the proposed requirement that the 
    comparative quantitative information be positioned adjacent to the most 
    prominent claim or to the nutrition label. However, in light of 
    Sec. 101.2(e), which states that all required information on the 
    information panel appear in one place without other intervening 
    material, the agency is concerned that the proposed codified language 
    pertaining to relative claims in Secs. 101.54, 101.56, 101.60, 101.61, 
    and 101.62 that would require quantitative information to be ``declared 
    adjacent to the most prominent claim or to the nutrition label * * *'' 
    might be interpreted to mean that when the [[Page 17205]] nutrition 
    label remains on the information panel, the quantitative information 
    has to be immediately adjacent to the nutrition label rather than being 
    allowed to be placed elsewhere on the information panel in proximity 
    with other required information, as is in fact the case. Such a literal 
    interpretation of the words ``adjacent to the nutrition label'' could 
    have the unintended effect of requiring current labels containing 
    relative claims to be redesigned for the sole purpose of relocating the 
    quantitative information. The same concern exists for 
    Sec. 101.61(c)(2)(iii), which addresses the placement of the statement 
    ``not a sodium free food'' on foods that are not sodium free and yet 
    whose label bears a claim of ``unsalted.''
        To prevent such a misunderstanding, FDA is modifying the codified 
    language pertaining to relative claims (i.e., ``more'' claims: 
    Sec. 101.54(e)(1)(iii)(B) and (e)(2)(iii)(B); ``light'' claims: 
    Sec. 101.56(b)(3)(ii), (c)(1)(ii)(B), (c)(2)(ii)(B), and (g); calorie 
    claims: Sec. 101.60(b)(5)(ii)(B), (b)(6)(ii)(B), (c)(4)(ii)(B), and 
    (c)(5)(ii)(B); sodium claims: Sec. 101.61(b)(6)(ii)(B) and 
    (b)(7)(ii)(B); and fat, fatty acid, and cholesterol claims: 
    Sec. 101.62(b)(4)(ii)(B), (b)(5)(ii)(B), (c)(4)(ii)(B), (c)(5)(ii)(B), 
    (d)(1)(ii)(F)(2), (d)(2)(iii)(E)(2), (d)(2)(iv)(E)(2), (d)(4)(i)(C)(2), 
    (d)(4)(ii)(D)(2), (d)(5)(i)(C)(2), and (d)(5)(ii)(D)(2)) and the 
    general principles governing nutrient content claims in 
    Sec. 101.13(j)(2)(iv)(B) (21 CFR 101.13(j)(2)(iv)(B)) to state that the 
    quantitative information ``shall appear adjacent to the most prominent 
    claim or to the nutrition label, except that if the nutrition label is 
    on the information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.'' 
    (For clarity, FDA is making a small change in the placement of the 
    illustrative example in these regulations and, for consistency, is 
    adding an example to Sec. 101.62(d)(4)(i)(C)(2).) Likewise, the agency 
    is modifying Sec. 101.61(c)(2)(iii), which pertains to the placement of 
    the statement ``not a low sodium food,'' to state that the statement 
    shall appear ``adjacent to the nutrition label of the food bearing the 
    claim, or, if the nutrition label is on the information panel, it may 
    appear elsewhere on the information panel in accordance with Sec. 101.2 
    of this chapter.''
    
    IV. Environmental Impact
    
        The agency previously considered the environmental effects of this 
    rule as announced in the proposed rule of August 18, 1993 (58 FR 
    44091). No new information or comments have been received that would 
    affect the agency's previous determination that there is no significant 
    impact on the human environment and that an environmental impact 
    statement is not required.
    
    V. Analysis of Impacts
    
        FDA has examined the impacts of the final rule under Executive 
    Order 12866 and the Regulatory Flexibility Act (Pub. L. 96-354). 
    Executive Order 12866 directs agencies to assess all costs and benefits 
    of available regulatory alternatives and, when regulation is necessary, 
    to select regulatory approaches that maximize net benefits (including 
    potential economic, environmental, public health and safety, and other 
    advantages; distributive impacts; and equity). The agency believes that 
    this final rule is consistent with the regulatory philosophy and 
    principles identified in the Executive Order. In addition, the final 
    rule is not a significant regulatory action as defined by the Executive 
    Order and so is not subject to review under the Executive Order.
        The Regulatory Flexibility Act requires agencies to analyze 
    regulatory options that would minimize any significant impact of a rule 
    on small entities. Because this final rule will allow for increased 
    flexibility in complying with labeling rules, and therefore results in 
    positive net benefits, the agency certifies that the final rule will 
    not have a significant economic impact on a substantial number of small 
    entities. Therefore, under the Regulatory Flexibility Act, no further 
    analysis is required.
    
    List of Subjects in 21 CFR Part 101
    
        Food labeling, Nutrition, Reporting and recordkeeping requirements.
    
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    101 is amended as follows:
    
    PART 101--FOOD LABELING
    
        1. The authority citation for 21 CFR part 101 continues to read as 
    follows:
    
        Authority: Secs. 4, 5, 6 of the Fair Packaging and Labeling Act 
    (5 U.S.C. 1453, 1454, 1455); secs. 201, 301, 402, 403, 409, 701 of 
    the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 342, 
    343, 348, 371).
    
        2. Section 101.2 is amended by revising paragraph (d)(1) to read as 
    follows:
    
    
    Sec. 101.2  Information panel of package form food.
    
    * * * * *
        (d)(1) Except as provided by Sec. 101.9(j)(13) and (j)(17), all 
    information required to appear on the principal display panel or on the 
    information panel pursuant to this section shall appear on the same 
    panel unless there is insufficient space. In determining the 
    sufficiency of the available space, except as provided by 
    Sec. 101.9(j)(17), any vignettes, designs, and other nonmandatory label 
    information shall not be considered. If there is insufficient space for 
    all of this information to appear on a single panel, it may be divided 
    between these two panels except that the information required pursuant 
    to any given section or part shall all appear on the same panel. A food 
    whose label is required to bear the ingredient statement on the 
    principal display panel may bear all other information specified in 
    paragraph (b) of this section on the information panel.
    * * * * *
        3. Section 101.9 is amended by revising paragraph (i) and by adding 
    new paragraph (j)(17) to read as follows:
    
    
    Sec. 101.9  Nutrition labeling of food.
    
    * * * * *
        (i) Except as provided in paragraphs (j)(13) and (j)(17) of this 
    section, the location of nutrition information on a label shall be in 
    compliance with Sec. 101.2.
        (j) * * *
        (17) Foods in packages that have a total surface area available to 
    bear labeling greater than 40 square inches but whose principal display 
    panel and information panel do not provide sufficient space to 
    accommodate all required information may use any alternate panel that 
    can be readily seen by consumers for the nutrition label. The space 
    needed for vignettes, designs, and other nonmandatory label information 
    on the principal display panel may be considered in determining the 
    sufficiency of available space on the principal display panel for the 
    nutrition label. Nonmandatory label information on the information 
    panel shall not be considered in determining the sufficiency of 
    available space for the nutrition label.
    * * * * *
        4. Section 101.13 is amended by revising paragraph (j)(2)(iv)(B) to 
    read as follows:
    
    
    Sec. 101.13  Nutrient content claims--general principles.
    
    * * * * *
        (j) * * *
        (2) * * *
        (iv) * * *
        (B) This statement shall appear adjacent to the most prominent 
    claim or to the nutrition label, except that if the nutrition label is 
    on the information [[Page 17206]] panel, the quantitative information 
    may be located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        5. Section 101.54 is amended by revising paragraphs (e)(1)(iii)(B) 
    and (e)(2)(iii)(B) to read as follows:
    
    
    Sec. 101.54  Nutrient content claims for ``good source,'' ``high,'' and 
    ``more.''
    
    * * * * *
        (e) * * *
        (1) * * *
        (iii) * * *
        (B) Quantitative information comparing the level of the nutrient in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Fiber content of white bread is 1 gram (g) per 
    serving; (this product) 3.5 g per serving'') is declared adjacent to 
    the most prominent claim or to the nutrition label, except that if the 
    nutrition label is on the information panel, the quantitative 
    information may be located elsewhere on the information panel in 
    accordance with Sec. 101.2.
        (2) * * *
        (iii) * * *
        (B) Quantitative information comparing the level of the nutrient in 
    the product per specified weight with that of the reference food that 
    it replaces (e.g., ``The fiber content of `X brand of product' is 2 g 
    per 3 oz. This product contains 4.5 g per 3 oz.'') is declared adjacent 
    to the most prominent claim or to the nutrition label, except that if 
    the nutrition label is on the information panel, the quantitative 
    information may be located elsewhere on the information panel in 
    accordance with Sec. 101.2.
        6. Section 101.56 is amended by revising paragraphs (b)(3)(ii), 
    (c)(1)(ii)(B), (c)(2)(ii)(B), and (g) to read as follows:
    
    
    Sec. 101.56  Nutrient content claims for ``light'' or ``lite.''
    
    * * * * *
        (b) * * *
        (3) * * *
        (ii) Quantitative information comparing the level of calories and 
    fat content in the product per labeled serving size with that of the 
    reference food that it replaces (e.g., ``lite cheesecake--200 calories, 
    4 grams (g) fat per serving; regular cheesecake--300 calories, 8 g fat 
    per serving'') is declared adjacent to the most prominent claim or to 
    the nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2; and
    * * * * *
        (c) * * *
        (1) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of sodium per 
    labeled serving size with that of the reference food that it replaces 
    (e.g., ``lite soy sauce 500 milligrams (mg) sodium per serving; regular 
    soy sauce 1,000 mg per serving'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
        (2) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of sodium per 
    labeled serving size with that of the reference food that it replaces 
    (e.g., ``lite canned peas, 175 mg sodium per serving; regular canned 
    peas 350 mg per serving'') is declared adjacent to the most prominent 
    claim or to the nutrition label, except that if the nutrition label is 
    on the information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        (g) The term ``lightly salted'' may be used on a product to which 
    has been added 50 percent less sodium than is normally added to the 
    reference food as described in Sec. 101.13(j)(1)(i)(B) and 
    (j)(1)(ii)(B), provided that if the product is not ``low in sodium'' as 
    defined in Sec. 101.61(b)(4), the statement ``not a low sodium food,'' 
    shall appear adjacent to the nutrition label of the food bearing the 
    claim, or, if the nutrition label is on the information panel, it may 
    appear elsewhere on the information panel in accordance with Sec. 101.2 
    and the information required to accompany a relative claim shall appear 
    on the label or labeling as specified in Sec. 101.13(j)(2).
        7. Section 101.60 is amended by revising paragraphs (b)(4)(ii)(B), 
    (b)(5)(ii)(B), (c)(4)(ii)(B), and (c)(5)(ii)(B) to read as follows:
    
    
    Sec. 101.60  Nutrient content claims for the calorie content of foods.
    
    * * * * *
        (b) * * *
        (4) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of the nutrient 
    per labeled serving size with that of the reference food that it 
    replaces (e.g., ``Calorie content has been reduced from 150 to 100 
    calories per serving.'') is declared adjacent to the most prominent 
    claim or to the nutrition label, except that if the nutrition label is 
    on the information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        (5) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of the nutrient in 
    the product per specified weight with that of the reference food that 
    it replaces (e.g., ``Calorie content has been reduced from 108 calories 
    per 3 oz to 83 calories per 3 oz.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        (c) * * *
        (4) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of the sugar in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Sugar content has been lowered from 8 g to 6 g per 
    serving.'') is declared adjacent to the most prominent claim or to the 
    nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
        (5) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of the nutrient in 
    the product per specified weight with that of the reference food that 
    it replaces (e.g., ``Sugar content has been reduced from 17 g per 3 oz 
    to 13 g per 3 oz.'') is declared adjacent to the most prominent claim 
    or to the nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
        8. Section 101.61 is amended by revising paragraphs (b)(6)(ii)(B), 
    (b)(7)(ii)(B), and (c)(2)(iii) to read as follows:
    
    
    Sec. 101.61  Nutrient content claims for the sodium content of foods.
    
    * * * * *
        (b) * * *
        (6) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of the sodium in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Sodium content has been lowered from 300 to 150 mg 
    per serving.'') is declared adjacent to the most prominent claim or to 
    the nutrition label, except that if the nutrition label is on the 
    information [[Page 17207]] panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        (7) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of sodium in the 
    product per specified weight with that of the reference food that it 
    replaces (e.g., ``Sodium content has been reduced from 217 mg per 3 oz 
    to 150 mg per 3 oz.'') is declared adjacent to the most prominent claim 
    or to the nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        (c) * * *
        (2) * * *
        (iii) If the food is not sodium free, the statement, ``not a sodium 
    free food'' or ``not for control of sodium in the diet'' appears 
    adjacent to the nutrition label of the food bearing the claim, or, if 
    the nutrition label is on the information panel, it may appear 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        9. Section 101.62 is amended by revising paragraphs (b)(4)(ii)(B), 
    (b)(5)(ii)(B), (c)(4)(ii)(B), (c)(5)(ii)(B), (d)(1)(ii)(F)(2), 
    (d)(2)(iii)(E)(2), (d)(2)(iv)(E)(2), (d)(4)(i)(C)(2), (d)(4)(ii)(D)(2), 
    (d)(5)(i)(C)(2), and (d)(5)(ii)(D)(2) to read as follows:
    
    
    Sec. 101.62  Nutrient content claims for fat, fatty acid, and 
    cholesterol content of foods.
    
    * * * * *
        (b) * * *
        (4) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of fat in the 
    product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Fat content has been reduced from 8 g to 4 g per 
    serving.'') is declared adjacent to the most prominent claim or to the 
    nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        (5) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of fat in the 
    product per specified weight with that of the reference food that it 
    replaces (e.g., ``Fat content has been reduced from 7.5 g per 3 oz to 5 
    g per 3 oz.'') is declared adjacent to the most prominent claim, to the 
    nutrition label, or, if the nutrition label is located on the 
    information panel, it may appear elsewhere on the information panel in 
    accordance with Sec. 101.2.
    * * * * *
        (c) * * *
        (4) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of saturated fat 
    in the product per labeled serving with that of the reference food that 
    it replaces (e.g., ``Saturated fat reduced from 3 g to 1.5 g per 
    serving'') is declared adjacent to the most prominent claim or to the 
    nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        (5) * * *
        (ii) * * *
        (B) Quantitative information comparing the level of saturated fat 
    in the product per specified weight with that of the reference food 
    that it replaces (e.g., ``Saturated fat content has been reduced from 
    2.5 g per 3 oz to 1.7 g per 3 oz.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label in on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        (d) * * *
        (1) * * *
        (ii) * * *
        (F) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Contains no cholesterol compared with 30 mg 
    cholesterol in one serving of butter. Contains 13 g of fat per 
    serving.'') is declared adjacent to the most prominent claim or to the 
    nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
        (2) * * *
        (iii) * * *
        (E) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Cholesterol lowered from 30 mg to 5 mg per serving; 
    contains 13 g of fat per serving.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
        (iv) * * *
        (E) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Cholesterol lowered from 30 mg to 5 mg per serving; 
    contains 13 g of fat per serving.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        (4) * * *
        (i) * * *
        (C) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``[labeled product] 50 mg cholesterol per serving; 
    [reference product] 30 mg cholesterol per serving'') is declared 
    adjacent to the most prominent claim or to the nutrition label, except 
    that if the nutrition label is on the information panel, the 
    quantitative information may be located elsewhere on the information 
    panel in accordance with Sec. 101.2.
        (ii) * * *
        (D) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per labeled serving with that of the reference food that it 
    replaces (e.g., ``Cholesterol lowered from 55 mg to 30 mg per serving. 
    Contains 13 g of fat per serving.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2.
    * * * * *
        (5) * * *
        (i) * * *
        (C) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per specified weight with that of the reference food that 
    it replaces (e.g., ``Cholesterol content has been reduced from 35 mg 
    per 3 oz to 25 mg per 3 oz.'') is declared adjacent to the most 
    prominent claim or to the nutrition label, except that if the nutrition 
    label is on the information panel, the quantitative information may be 
    located elsewhere on the information panel in accordance with 
    Sec. 101.2. [[Page 17208]] 
        (ii) * * *
        (D) * * *
        (2) Quantitative information comparing the level of cholesterol in 
    the product per specified weight with that of the reference food that 
    it replaces (e.g., ``Cholesterol lowered from 30 mg to 22 mg per 3 oz 
    of product.'') is declared adjacent to the most prominent claim or to 
    the nutrition label, except that if the nutrition label is on the 
    information panel, the quantitative information may be located 
    elsewhere on the information panel in accordance with Sec. 101.2.
    * * * * *
        Dated: March 24, 1995.
    William B. Schultz,
    Deputy Commissioner for Policy.
    [FR Doc. 95-8067 Filed 3-31-95; 4:32 pm]
    BILLING CODE 4160-01-P
    
    

Document Information

Effective Date:
5/5/1995
Published:
04/05/1995
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
95-8067
Dates:
May 5, 1995.
Pages:
17202-17208 (7 pages)
Docket Numbers:
Docket No. 93N-0283
RINs:
0905-AD89
PDF File:
95-8067.pdf
CFR: (18)
21 CFR 101.4(a)(1)
21 CFR 101.56(b)(3)(ii)
21 CFR 101.61(c)(2)(iii)
21 CFR 101.2(d)(1)
21 CFR 101.2(e)
More ...